HVO

Hvivo (HVO)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HVO
DataOraFonteTitoloSimboloCompagnia
13/05/202414:02RNS Regulatory NewshVIVO PLC Result of AGMLSE:HVOHvivo Plc
15/04/202408:00RNS Regulatory NewshVIVO PLC Annual Report & Notice of AGMLSE:HVOHvivo Plc
09/04/202413:03Alliance NewsAlliance NewshVIVO swings to profit and commences annual dividends as outlook rosyLSE:HVOHvivo Plc
09/04/202408:09RNS Regulatory NewshVIVO PLC Final resultsLSE:HVOHvivo Plc
27/03/202408:00RNS Regulatory NewshVIVO PLC Notice of ResultsLSE:HVOHvivo Plc
22/03/202416:03RNS Regulatory NewshVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
15/02/202408:00RNS Regulatory NewshVIVO PLC Long Term Incentive Plan / PDMR NotificationLSE:HVOHvivo Plc
14/02/202420:55Alliance NewsAlliance NewsIN BRIEF: hVIVO Chair and non-exec director sell 30.0 million sharesLSE:HVOHvivo Plc
14/02/202414:14RNS Regulatory NewshVIVO PLC Result of Secondary PlacingLSE:HVOHvivo Plc
14/02/202411:46Alliance NewsAlliance NewsIN BRIEF: hVIVO directors to sell total of 14 million sharesLSE:HVOHvivo Plc
14/02/202408:00RNS Regulatory NewshVIVO PLC Proposed Secondary Placing of Ordinary SharesLSE:HVOHvivo Plc
30/01/202412:39Alliance NewsAlliance NewshVIVO shares up after "record year" across all metricsLSE:HVOHvivo Plc
30/01/202408:00RNS Regulatory NewshVIVO PLC Trading updateLSE:HVOHvivo Plc
08/01/202408:00UK RegulatoryhVIVO PLC Broker changeLSE:HVOHvivo Plc
02/01/202411:16Alliance NewsAlliance NewshVIVO inks GBP6.3 million deal to test common cold treatmentLSE:HVOHvivo Plc
02/01/202408:00UK RegulatoryhVIVO PLC GBP6.3m HRV contract signed with biotech clientLSE:HVOHvivo Plc
13/12/202312:44Alliance NewsAlliance NewshVIVO signs deal to test RSV antiviral drug candidate with study modelLSE:HVOHvivo Plc
13/12/202308:00UK RegulatoryhVIVO PLC GBP16.8m RSV contract & Trading ahead of guidanceLSE:HVOHvivo Plc
05/10/202312:45Alliance NewsAlliance NewshVIVO celebrates positive results for Pneumagen's Neumifil in trialLSE:HVOHvivo Plc
05/10/202308:00RNS Non-RegulatoryhVIVO PLC Positive results from flu human challenge studyLSE:HVOHvivo Plc
12/09/202312:33Alliance NewsAlliance NewshVIVO interim profit jumps on revenue increase; ups full-year guidanceLSE:HVOHvivo Plc
12/09/202308:00UK RegulatoryhVIVO PLC Interim resultsLSE:HVOHvivo Plc
01/09/202308:00UK RegulatoryhVIVO PLC Exercise of WarrantsLSE:HVOHvivo Plc
29/08/202312:32Alliance NewsAlliance NewshVIVO announces plans for new Canary Wharf facility as demand growsLSE:HVOHvivo Plc
29/08/202308:00UK RegulatoryhVIVO PLC Plans for a new larger state-of-the-art facilityLSE:HVOHvivo Plc
26/07/202315:29Alliance NewsAlliance NewsIN BRIEF: hVIVO interim revenue grows; in line with expectationsLSE:HVOHvivo Plc
25/07/202315:25Alliance NewsAlliance NewshVIVO secures GBP13.1 million contract for influenza B modelLSE:HVOHvivo Plc
25/07/202308:00UK RegulatoryhVIVO PLC Flu B challenge modelLSE:HVOHvivo Plc
28/06/202315:16Alliance NewsAlliance NewshVIVO inks deal to manufacture human hMPV virus for challenge trialLSE:HVOHvivo Plc
28/06/202308:00UK RegulatoryhVIVO PLC hMPV human challenge modelLSE:HVOHvivo Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:HVO

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network